跳至主要内容
临床试验/NCT05183529
NCT05183529已完成不适用

Monitoring Vital Signs With a Wireless Ingestible Device in Subjects Undergoing Polysomnography

Celero Systems, Inc.2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年12月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
2
主要终点
Evaluate the ability of the VM Pill to monitor respiration from within the GI tract

研究概览

简要总结

This Minimal Risk study is designed to evaluate the ability of the Celero ingestible Vitals Monitoring Pill (i.e., VM Pill) to measure respiration from within the gastrointestinal tract, in addition to performing an exploratory comparative analysis of data collected by the VM Pill and data collected from clinical monitoring sensors as part of polysomnography.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy individuals ages 18 - 65 inclusive who are indicated for a polysomnography study.

排除标准

  • Patients with a history of abdominal surgery and/or any condition that may impact the GI tract, including but not limited to:
  • Constipation
  • Esophageal stricture
  • Esophagitis
  • Gastritis
  • Gastric ulcers
  • Peptic ulcer
  • Gallstones
  • Celiac Disease
  • Crohn's Disease
  • Ulcerative Colitis
  • Irritable Bowel Syndrome
  • Diverticulitis
  • Colorectal cancer

结局指标

主要结局

Evaluate the ability of the VM Pill to monitor respiration from within the GI tract

时间窗: During polysomnography

Mean absolute error between respiratory rate measured by the VM Pill and respiratory rate measured by PSG monitoring equipment during periods of normal breathing while the patient is sleeping or at rest.

次要结局

未报告次要终点

研究者

发起方
Celero Systems, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Monitoring Vital Signs With a Wireless Ingestible... | 临床试验